The trajectory of companies tied to the drug's legacy presents a intricate investment scenario . While the initial surge generated substantial returns , generic alternatives have significantly eroded sales https://adult816654.blogsumer.com/40640965/copyright-s-flagship-product-and-big-pharma-a-uncertain-venture